Objective: The experience of end-stage renal failure (ESRF) should not be understood merely in terms of functional impairment and increases in emotional distress. It should be assessed in its own right. Qualitative research is necessary for describing patients' own experience of ESRF so that findings are not influenced by psychological theory.
Method: The typical sampling method was used to select the sample, which consisted of 16 hemodialysis patients. Thematic analysis of patient interviews followed established conventions so as to ground the analysis in the data, rather than pre-existing ideas.
Results: Qualitative analysis identified different ways in which the patients evaluated their lives. The patients described the effects of ESRF on their lives primarily in terms of attitudes towards limitations, mixed feelings about caregivers, and changes in their own character. Caregivers were frequently described as supportive, but patients also perceived them as sources of distress and difficulty. ESRF and its treatment were reported to have worsened not only the patients' emotional states, but also aspects of their character; however, the effect of ESRF also involved the experience of positive changes in character.
Conclusion: The present study provides a detailed systematic account of how hemodialysis patients evaluated their lives. Some of the findings provide details about how the psychological processes that have been previously reported operate in practice, which clinicians and researchers need to understand; however, some findings cannot readily be explained according to existing ideas. The findings, therefore, identify potential targets for educational intervention to improve patient adjustment.
Download full-text PDF |
Source |
---|
Biosci Microbiota Food Health
July 2024
Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
In end-stage kidney disease requiring hemodialysis, patients at nutritional risk have a poor prognosis. The gut microbiota is important for maintaining the nutritional status of patients. However, it remains unclear whether an altered gut microbiota correlates with increased nutritional risk in patients undergoing hemodialysis.
View Article and Find Full Text PDFCan J Kidney Health Dis
January 2025
Division of Nephrology, Department of Medicine, Ottawa Hospital, University of Ottawa, ON, Canada.
Background: Patients with end-stage kidney disease (ESKD) have high rates of gastrointestinal bleeding due to several risk factors including platelet dysfunction, comorbid illness, and use of antiplatelet medications. Proton pump inhibitors (PPIs) reduce gastrointestinal bleeding and are recommended for high-risk patients such as those prescribed dual antiplatelet therapy (DAPT). Whether inappropriate duration of DAPT therapy and/or lack of appropriate PPI use contribute to the known elevated risk of gastrointestinal bleeding in hemodialysis patients is not known.
View Article and Find Full Text PDFPeerJ
January 2025
Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Background: Patients with end-stage renal disease (ESRD) have increased insulin resistance (IR). The triglyceride glucose (TyG) index is a marker of IR and is associated with the prognosis of patients on maintenance hemodialysis (MHD). The aim of this study was to examine the relationship between the TyG index and the risk of death in patients on MHD.
View Article and Find Full Text PDFBackground And Aim: Carnitine deficiency contributes to various comorbidities in maintenance hemodialysis (MHD) patients. This study aims to assess the impact of levocarnitine supplementation on hematological and serum iron profile parameters, comparing the efficacy of oral versus intravenous (IV) administration in these patients.
Materials And Methods: This was a multicenter, randomized controlled trial was conducted on patients undergoing MHD at the hemodialysis unit of our study center in Karachi, Pakistan.
Front Nephrol
December 2024
Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Chronic kidney disease (CKD) patients often suffer from complications such as anemia as the kidney function declines. More than 25% of CKD hemodialysis patients in China are complicated with renal anemia due to renal and hepatic impairment in the production of erythropoietin (EPO). In recent years, prolyl hydroxylase domain (PHD) inhibitors have been approved in China and Japan for the treatment of CKD patients complicated with anemia.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!